<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Endo Pharmaceuticals Holdings Inc.
------------------------------------------------------------
(Name of Issuer)
Common Stock
$.01 par value per share
------------------------------------------------------------
(Title of Class and Securities)
29264F 20 5
------------------------------------------------------------
(CUSIP Number)
James J. Connors, II Joseph B. Wollard
Endo Pharma LLC Citigroup Inc.
320 Park Avenue 425 Park Avenue
New York, New York 10022 New York, New York 10043
(212) 751-3939 (212) 793-7167
with a copy to: with a copy to:
Eileen T. Nugent, Esq. Beth Pagel Serebransky
Skadden, Arps, Slate, Meagher & Flom LLP Debevoise & Plimpton
4 Times Square 875 Third Avenue
New York, New York 10036-6522 New York, New York 10022
(212) 735-3000 Direct Dial: (212) 909-6785
------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
July 17, 2000
------------------------------------------------------------
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rules 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
to whom copies are to be sent.
Page 1 of 39
(Continued on following pages)
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Endo Pharma LLC
Application for I.R.S. Identification Number is Pending
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
SC
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF 70,938,030
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON 70,938,030
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
OO
-------------------------------------------------------------------
Page 2 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Kelso Investment Associates V, L.P.
13-372-8774
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
Page 3 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Kelso Equity Partners V, L.P.
13-3787708
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
Page 4 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Kelso Partners V, L.P.
13-3728773
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
------------------------------------------------------------------
Page 5 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Joseph S. Schuchert
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 6 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Frank T. Nickell
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 7 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Michael B. Goldberg
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 8 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
George E. Matelich
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 9 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Frank K. Bynum, Jr.
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 10 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Thomas R. Wall, IV
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 11 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
David I. Wahrhaftig
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 12 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Philip E. Berney
###-##-####
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 70,938,030
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
70,938,030
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
70,938,030
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
79.562%
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-------------------------------------------------------------------
Page 13 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Greenwich Street Capital Partners, L.P.
13-379-6268
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
Page 14 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Greenwich Street Capital Offshore Fund, Ltd.
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
British Virgin Islands
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------
Page 15 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
TRV Employees Fund, L.P.
13-379-6261
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
Page 16 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
The Travelers Insurance Company
06-0566090
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Connecticut
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------
Page 17 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
The Travelers Life and Annuity Company
06-090-4249
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Connecticut
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
-------------------------------------------------------------------
Page 18 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
-------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Greenwich Street Investments L.P.
13-379-6259
-------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
-------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
-------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
-------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
-------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
-------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
-------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
-------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
PN
-------------------------------------------------------------------
Page 19 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Citigroup Inc.
52-1568099
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY 63,100
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
63,100
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
63,100
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
Less than 1%
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
---------------------------------------------------------------------
Page 20 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Greenwich Street Investments, L.L.C.
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
---------------------------------------------------------------------
Page 21 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Greenwich Street Capital Partners, Inc.
06-139-3602
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
---------------------------------------------------------------------
Page 22 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
TRV Employees Investments, Inc.
13-379-6277
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
---------------------------------------------------------------------
Page 23 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Alfred C. Eckert III
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
---------------------------------------------------------------------
Page 24 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Keith W. Abell
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
---------------------------------------------------------------------
Page 25 of 39
<PAGE>
SCHEDULE 13D
CUSIP No. 29264F 20 5
---------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
Sanjay H. Patel
---------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) ( )
(b) (X)
---------------------------------------------------------------------
3. SEC USE ONLY
---------------------------------------------------------------------
4. SOURCE OF FUNDS
N/A
---------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) ( )
---------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
India
---------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF None
SHARES _____________________________________
BENEFICIALLY 8. SHARED VOTING POWER
OWNED BY None
EACH _____________________________________
REPORTING 9. SOLE DISPOSITIVE POWER
PERSON None
WITH _____________________________________
10. SHARED DISPOSITIVE POWER
None
---------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
None
---------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN
SHARES ( )
---------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
None
---------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
---------------------------------------------------------------------
Page 26 of 39
<PAGE>
Item 1. Security and Issuer.
-------------------
This statement on Schedule 13D ("Schedule 13D") is being filed pursuant to
Rule 13d-1 of the Rules and Regulations under the Securities Exchange Act of
1934, as amended (the "Exchange Act"), with respect to the common stock, par
value $.01 per share (the "Common Stock"), of Endo Pharmaceuticals Holdings Inc.
(the "Issuer" or "Endo"). The principal executive offices of the Issuer are
located at 223 Wilmington-West Chester Pike, Chadds Ford, Pennsylvania 19317.
Item 2. Identity and Background.
-----------------------
(a) This Schedule 13D is being filed jointly by Endo Pharma LLC, a limited
liability company organized under the laws of the State of Delaware ("Endo
LLC"); Kelso Investment Associates V, L.P., a limited partnership organized
under the laws of the State of Delaware ("KIA V"); Kelso Equity Partners V,
L.P., a limited partnership organized under the laws of the State of Delaware
("KEP V"); Kelso Partners V, L.P., a limited partnership organized under the
laws of the State of Delaware and the general partner of KIA V ("KP V"); Frank
T. Nickell, Thomas R. Wall, IV, George E. Matelich, Michael B. Goldberg, David
I. Wahrhaftig, Frank K. Bynum, Jr., Philip E. Berney and Joseph S. Schuchert,
each of whom is a general partner of KP V and of KEP V (such individuals,
collectively, the "Kelso General Partners"); Greenwich Street Capital Partners,
L.P. a limited partnership organized under the laws of the State of Delaware
("GSCP"); Greenwich Street Capital Offshore Fund, Ltd., a British Virgin Islands
international business company ("GSC Offshore"); TRV Employees Fund, L.P., a
limited partnership organized under the laws of the State of Delaware ("TRV
Fund" and together with GSCP and GSC Offshore, the "Greenwich Funds"); The
Travelers Insurance Company, a Connecticut corporation ("TIC"); The Travelers
Life and Annuity Company, a Connecticut corporation ("TLAC"); Greenwich Street
Investments, L.P., a limited partnership organized under the laws of the State
of Delaware ("GSI"); Citigroup Inc., a Delaware corporation ("Citigroup");
Greenwich Street Investments, L.L.C., a limited liability company organized
under the laws of the State of Delaware("GSILLC"); Greenwich Street Capital
Partners, Inc., a Delaware corporation ("GSCPI"); TRV Employees Investments,
Inc., a Delaware corporation ("TRVEII"); and Alfred C. Eckert III, Keith W.
Abell and Sanjay H. Patel (such individuals, collectively, the "GS Managing
Members"). (Endo LLC, KIA V, KEP V, KP V, the Kelso General Partners, GSCP, GSC
Offshore, TRV Fund, TIC, TLAC, GSI, Citigroup, GSILLC, GSCPI and the GS Managing
Members, are referred to herein as the "Filing Persons"). The Filing Persons
hereby disclaim beneficial ownership of any shares of the Common Stock that may
be beneficially owned by Endo LLC, and the filing of this statement shall not be
construed as an admission that the Filing Persons are, for purposes of Section
13(d) of the Exchange Act, the beneficial owners of any such shares of Common
Stock. Information with respect to each Filing Person is given solely by such
Filing Person and no Filing Person has responsibility for the accuracy or
completeness of information supplied by any other Filing Person.
(b) The principal business address for each of Endo LLC, KIA V, KEP V,
KP V and the Kelso General Partners is c/o Kelso & Company, 320 Park Avenue,
24/th/ Floor, New York, New York 10022. The principal business address for
each of GSCP, TRV Fund, GSI, GSILLC, GSCPI, TRVEII and the GS Managing Members
is 388 Greenwich Street, New York, NY 10013. The principal business address for
GSC Offshore is c/o Louise Chippendale Rawlinson & Hunter Ltd., Woodburne Hall,
P.O.
Page 27 of 39
<PAGE>
Box 3162, Road Town, Tortola, British Virgin Islands. The principal
business address for each of TIC and TLAC is One Tower Square, Hartford,
Connecticut 06183. The principal business address for Citigroup is 399 Park
Avenue, New York, New York 10043.
(c) Endo LLC was formed for the purpose of acquiring and holding shares of
the Common Stock of the Issuer in connection with the merger (the "Merger") of
Algos Pharmaceutical Corporation, a Delaware corporation ("Algos"), with and
into Endo Inc., a Delaware corporation and newly formed, wholly owned subsidiary
of the Issuer ("Sub"), pursuant to an Agreement and Plan of Merger, dated as of
November 26, 1999, by and among Endo, Sub and Algos (as may be amended and
restated from time to time, the "Merger Agreement").
KIA V and KEP V are private investment vehicles formed for the purpose of
investing in transactions arranged by Kelso & Company, a private investment firm
specializing in acquisition transactions ("Kelso"). The present principal
occupation of each of the Kelso General Partners is as follows: Mr. Schuchert is
Chairman of Kelso; Mr. Nickell is President of Kelso; Mr. Goldberg is Managing
Director of Kelso; Mr. Matelich is Managing Director of Kelso; Mr. Bynum is
Managing Director of Kelso; Mr. Wall is Managing Director of Kelso; Mr.
Wahrhaftig is Managing Director of Kelso and Mr. Berney is Managing Director
of Kelso.
GSCP, GSC Offshore, and TRV Fund are private investment funds. GSI is the
general partner of GSCP and GSILLC is the managing general partner of GSI. GSCPI
is the manager of GSC Offshore and GSCP. TRVEII is the general partner of TRV
Fund. Each of Messrs. Eckert, Abell and Patel is a general partner of GSI and
an executive employee of GSILLC, GSCPI and TRVEII.
Citigroup is a diversified holding company whose businesses provide a broad
range of financial services to consumer and corporate customers. TIC is an
indirect wholly-owned subsidiary of Citigroup and is engaged in life insurance
services. TLAC is a wholly-owned subsidiary of TIC and is engaged in life and
annuity insurance services.
(d)-(e) During the last five years, none of the Filing Persons and to
the best of each of the Filing Persons' knowledge, any of their respective
executive officers, controlling persons or directors has been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors) or
has been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction resulting in a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, federal
or state securities laws, or finding any violation with respect to such laws.
(f) All Filing Persons who are natural persons (other than Mr. Patel) are
citizens of the United States. Mr. Patel is a citizen of India. Endo LLC, KIA
V, KEP V, KP V, GSCP, TRV Fund, Citigroup, GSI, GSILLC, GSCPI and TRVEII are
each organized under the laws of the State of Delaware. GSC Offshore is
organized under the laws of the British Virgin Islands. TIC and TLAC are each
organized under the laws of the State of Connecticut.
Page 28 of 39
<PAGE>
Item 3. Source and Amount of Funds or Other Consideration.
-------------------------------------------------
Endo LLC acquired beneficial ownership of 70,938,030 shares of Common Stock
(the "Shares") pursuant to certain exchange agreements, dated as of July 14,
2000 (the "Exchange Agreements"), by and between Endo LLC, KIA V, the Greenwich
Funds, TIC and TLAC as well as certain other stockholders (all of such
stockholders, the "Exchanging Stockholders") of the Issuer. Under the terms
and subject to the conditions of the Exchange Agreements, the Exchanging
Stockholders exchanged all of the equity securities of the Issuer previously
owned by them for a number of membership interests ("Units") in Endo LLC.
The above description herein of the Exchange Agreements does not purport to
be complete and is qualified in their entirety by reference to the form of
Exchange Agreement, a copy of which is attached hereto as Exhibit 1.
Item 4. Purpose of Transaction.
----------------------
Endo LLC acquired the shares of Common Stock in connection with the Merger
and to fulfill certain obligations of the Issuer contained in the Merger
Agreement. Specifically, as described in Endo's Registration Statement on Form
S-4, Endo LLC acquired the shares of Common Stock prior to the Merger in order
to ensure that (i) the employee stock options of the Issuer that were
outstanding immediately prior to the Merger will only affect those holders of
the Common Stock who held such shares prior to the Merger and (ii) the Algos
stockholders' percentage ownership of Endo will increase by an additional five
percentage points in the event Endo does not achieve a cash gross profit
(based on pre-Merger Endo products and future non-Algos related products
internally developed and sold or marketed by Endo) for fiscal year 2000 of at
least $147.4 million. Endo LLC entered into the agreements described in Item 6
hereof in order to effect these transactions.
In connection with the Merger, with respect to each share of Common Stock
that it owns, Endo issued to Endo LLC one warrant (the "Endo Warrant") to
purchase up to 29,557,513 additional shares of Common Stock in the event that
the Food and Drug Administration does not approve MorphiDex(R) prior to
December 31, 2002. The exercise price of the Endo Warrant is $.01 per share.
There can be no assurance that Endo LLC will acquire additional shares of
Common Stock pursuant to the exercise of the Endo Warrant. This description
of the Endo Warrant does not purport to be complete and is qualified in its
entirety by reference to (1) the warrant agreement, dated as of July 17, 2000
(the "Pre-Merger Warrant Agreement"), by and between Endo and United States
Trust Company of New York, as warrant agent, and (2) the Endo Warrant, copies
of which are attached hereto as Exhibits 2 and 3, respectively.
Other than as set forth above, the Filing Persons do not currently have
any plans or proposals, other than those described in Item 4 and Item 6 of this
Schedule 13D, which relate to or would result in any of the actions or
transactions in clauses (a) through (j) of Item 4 of Schedule 13D. The Filing
Persons may from time to time discuss among themselves and with other persons
market conditions and other factors concerning their investment in the Issuer,
as well as specific actions that might be taken in light of prevailing
circumstances with respect to such interests.
Page 29 of 39
<PAGE>
The Filing Persons reserve the right from time to time to acquire or
dispose of the Shares or the Endo Warrant, or to formulate other purposes,
plans or proposals regarding the Issuer or the Shares or the Endo Warrant held
by the Filing Persons to the extent deemed advisable in light of general
investment policies, market conditions and other factors.
Item 5. Interest in Securities of the Issuer.
------------------------------------
(a)-(b)
Endo LLC
--------
As of July 26, 2000, the aggregate number of shares of the Common Stock
that Endo LLC has the sole power to vote or to direct the vote of (and as a
result, may, under Rule 13d-3 under the Exchange Act, be deemed the beneficial
owner of) is 70,938,030. This number represents approximately 79.562% of the
89,160,530 shares of such Common Stock outstanding as of July 26, 2000. Endo LLC
hereby disclaims beneficial ownership of the securities reported herein.
All Other Filing Persons
------------------------
Because of their direct or indirect ownership of the majority of the Units
of Endo LLC, KIA V, KEP V, KP V and the Kelso General Partners may be deemed as
possessing the shared power to vote or to direct the vote (and as a result, may
under Rule 13d-3 under the Exchange Act, be deemed the beneficial owner of) an
aggregate of 70,938,030 shares of Common Stock. This number of shares represent
approximately 79.562% of the 89,160,530 shares of such Common Stock outstanding
as of July 24, 2000. However, all such Filing Persons (including Endo LLC)
disclaim beneficial ownership of such shares of Common Stock.
Certain subsidiaries of Citigroup beneficially own 63,100 shares of Common
Stock as of July 24, 2000.
(c) Except as set forth in Item 5, to the best knowledge of each Filing
Person, none of the Filing Persons and no other person described in Item 2
hereof has beneficial ownership of, or has engaged in any transaction during the
past 60 days in, any shares of Common Stock.
(d) None of the Filing Persons, to the best knowledge of each Filing
Person, has the right to receive or to the power to direct the receipt of
dividends from, or the proceeds from the sale of, the Shares.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships
--------------------------------------------------------
With Respect to Securities of the Issuer.
----------------------------------------
Except as set forth in this Statement, to the best knowledge of the Filing
Persons, there are no other contracts, arrangements, understandings or
Page 30 of 39
<PAGE>
relationships (legal or otherwise) among the persons named in Item 2 and between
such persons and any person with respect to any securities of the Issuer,
including, but not limited to, transfers or voting of any securities, finder's
fees, joint ventures, loan or option arrangements, puts or calls, guarantees of
profits, division of profits or loss, or the giving or withholding of proxies.
On November 26, 1999, Algos, KIA V, KEP V and Endo entered into a letter
agreement (the "Letter Agreement"), pursuant to which, in order to induce Algos
to enter into the Merger Agreement, KIA V and KEP V agreed that, for a period of
two years from the effective time of the Merger, they will not, and will cause
any of its affiliates to which either of KIA V or KEP V has transferred any
shares of Common Stock (other than Endo and any of Endo's subsidiaries) not to,
engage in certain transactions with respect to Endo.
On July 14, 2000, the Exchanging Stockholders entered into a limited
liability company agreement of Endo LLC (the "LLC Agreement"). The LLC Agreement
governs the operation of the Issuer.
On July 14, 2000, Endo LLC adopted the (i) Amended and Restated 1997
Employee Stock Option Plan (the "Amended 1997 Employee Plan") and (ii) Amended
and Restated 1997 Executive Stock Option Plan (the "Amended 1997 Executive
Plan") to provide, among other things, that the stock options granted pursuant
to these plans will be exercisable solely into shares of Common Stock held by
Endo LLC, (iii) 2000 Supplemental Employee Stock Option Plan (the "2000 Employee
Plan") and (iv) 2000 Supplemental Executive Stock Option Plan (the "2000
Executive Plan" and together with the Amended 1997 Employee Plan, the Amended
1997 Executive Plan and the 2000 Supplemental Employee Plan, the "LLC Plans"),
pursuant to which Endo LLC will grant options to purchase shares of Common Stock
held by it to certain executives and employees, respectively, of Endo and its
subsidiaries.
Endo, Endo LLC, KIA V, KEP V and the Management Stockholders (as defined
therein) entered into an amended and restated executive stockholders agreement
as of July 14, 2000 (the "Executive Stockholders Agreement"). Endo, Endo LLC,
KIA V, KEP V and the Employee Stockholders (as defined therein) entered into an
amended and restated employee stockholders agreement as of July 14, 2000 (the
"Employee Stockholders Agreement").
On July 17, 2000, Endo, Sub and Endo LLC entered into a tax sharing
agreement (the "Tax Sharing Agreement"), pursuant to which, in general, Endo
will pay to Endo LLC the amount of the tax benefits Endo receives as a result of
the exercise of employee stock options granted under the LLC Plans to employees
of Endo.
On July 17, 2000, Endo and Endo LLC entered into an agreement (the
"Treasury Agreement"), pursuant to which Endo LLC agreed to comply with Section
5.21 of the Merger Agreement and return a number of shares of Common Stock it
owns to Endo's treasury in the event that the cash gross profit of Endo for
fiscal year 2000 is less than $147.4 million thereby increasing the Algos
stockholders ownership in Endo by five percentage points.
On July 17, 2000, Endo and Endo LLC entered into a registration rights
agreement (the "Registration Rights Agreement"), which provides Endo LLC with
registration rights with respect to the shares of Common Stock owned by it. The
Registration Rights Agreement provides, among other things, for the registration
with the Securities and Exchange Commission of the shares of Common Stock it
Page 31 of 39
<PAGE>
owns. Pursuant to the terms of the Registration Rights Agreement, Endo LLC
shall be entitled to six "demand registrations." The Registration Rights
Agreement further provides that Endo LLC shall have "piggyback" registration
rights with respect to any registration of Common Stock, subject to customary
"black-out" and "hold-back" provisions.
The descriptions herein of each of the Letter Agreement, LLC Agreement,
Amended Executive Stockholders Agreement, Amended Employee Stockholders
Agreement, Amended 1997 Employee Stock Option Plan, Amended 1997 Executive Stock
Option Plan, 2000 Employee Stock Option Plan, 2000 Executive Stock Option Plan,
Tax Sharing Agreement, Treasury Agreement and Registration Rights Agreement do
not purport to be complete and are qualified in their entirety by reference to
each of the Letter Agreement, LLC Agreement, Amended Executive Stockholders
Agreement, Amended Employee Stockholders Agreement, Amended 1997 Employee Stock
Option Plan, Amended 1997 Executive Stock Option Plan, 2000 Employee Stock
Option Plan, 2000 Executive Stock Option Plan, Tax Sharing Agreement, Treasury
Agreement and Registration Rights Agreement, copies of which are attached hereto
as Exhibits 4-14, respectively and are incorporated herein by reference.
Item 7. Materials to be Filed as Exhibits.
----------------------------------
Exhibit Description
------- -----------
1. Form of Exchange Agreement, by and between Endo
Pharmaceuticals Holdings Inc. ("Endo") and the
stockholders party thereto
2. Endo Warrant, dated as of July 17, 2000, issued
by Endo to Endo Pharma LLC ("Endo LLC")
3. Pre-Merger Warrant Agreement, dated as of July 17,
2000, by and between Endo and United States Trust
Company of New York, as warrant agent
4. Letter Agreement, dated as of November 26, 1999,
by and among Algos Pharmaceutical Corporation,
Endo, Kelso Investment Associates V, L.P. ("KIA
V") and Kelso Equity Partners V, L.P. ("KEP V")
5. Limited Liability Company Agreement of Endo LLC
("Endo LLC"), dated as of July 14, 2000, by and
among the persons party thereto and
Page 32 of 39
<PAGE>
each of their Permitted Transferees (as defined
therein)
6. Amended and Restated Executive Stockholders
Agreement, dated as of July 14, 2000, by and among
Endo, Endo LLC, KIA V, KEP V and the Management
Stockholders (as defined therein)
7. Amended and Restated Employee Stockholders
Agreement, dated as of July 14, 2000, by and among
Endo, Endo LLC, KIA V, KEP V and the Employee
Stockholders (as defined therein)
8. Endo LLC Amended and Restated 1997 Employee Stock
Option Plan
9. Endo LLC Amended and Restated 1997 Executive Stock
Option Plan
10. Endo LLC 2000 Supplemental Employee Option Plan
11. Endo LLC 2000 Supplemental Executive Option Plan
12. Tax Sharing Agreement, dated as of July 17, 2000,
by and among Endo, Endo Inc. and Endo LLC
13. Treasury Agreement, dated as of July 17, 2000, by
and between Endo and Endo LLC
14. Registration Rights Agreement, dated as of July
17, 2000, by and between Endo and Endo LLC
15. Joint Filing Agreement, dated as of July 26, 2000
16. Powers of Attorney
Page 33 of 39
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
Dated: July 27, 2000 ENDO PHARMA LLC
By:/s/ Jeffrey R. Black
---------------------------------
Name: Jeffrey R. Black
Title: Chief Financial Officer
KELSO INVESTMENT ASSOCIATES V, L.P.
By: Kelso Partners V, L.P., its
General Partner
By:/s/ Michael B. Goldberg
---------------------------------
KELSO EQUITY PARTNERS V, L.P.
By:/s/ Michael B. Goldberg
---------------------------------
KELSO PARTNERS V, L.P.
By:/s/ Michael B. Goldberg
---------------------------------
*
------------------------------------
Joseph S. Schuchert
*
------------------------------------
Frank T. Nickell
*
------------------------------------
George E. Matelich
Page 34 of 39
<PAGE>
*
----------------------------------------
Thomas R. Wall, IV
*
----------------------------------------
Frank K. Bynum, Jr.
*
----------------------------------------
Michael B. Goldberg
*
----------------------------------------
David I. Wahrhaftig
*
----------------------------------------
Philip E. Berney
GREENWICH STREET CAPITAL PARTNERS, L.P.
By: Greenwich Street Investments, L.P.,
its general partner
By: Greenwich Street Investments, L.L.C.,
General Partner
By:/s/ Eric S. Bomze
-------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
GREENWICH STREET CAPITAL OFFSHORE FUND, LTD.
By: Greenwich Street Capital Partners, Inc.,
as Manager
By:/s/ Eric S. Bomze
-------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
TRV EMPLOYEES FUND, L.P.
By: TRV Employees Investments, Inc.
its general partner
By:/s/ Eric S. Bomze
-------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
Page 35 of 39
<PAGE>
THE TRAVELERS INSURANCE COMPANY
By: /s/ Millie Kim
-------------------------------------
Name: Millie Kim
Title: Assistant Secretary
THE TRAVELERS LIFE AND ANNUITY COMPANY
By: /s/ Millie Kim
-------------------------------------
Name: Millie Kim
Title: Assistant Secretary
CITIGROUP INC.
By:/s/ Joseph B. Wollard
------------------------------------
Name: Joseph B. Wollard
Title: Assistant Secretary
GREENWICH STREET INVESTMENTS, L.P.
By: Greenwich Street Investments, L.L.C.,
General Partner
By:/s/ Eric S. Bomze
------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
GREENWICH STREET INVESTMENTS, L.L.C.
By:/s/ Eric S. Bomze
------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
GREENWICH STREET CAPITAL PARTNERS, INC.
By:/s/ Eric S. Bomze
------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
TRV EMPLOYEES INVESTMENTS, INC.
By:/s/ Eric S. Bomze
------------------------------------
Name: Eric S. Bomze
Title: Assistant Vice President
/s/ Alfred C. Eckert III
----------------------------------------
Alfred C. Eckert III
Page 36 of 39
<PAGE>
/s/ Keith W. Abell
----------------------------------------
Keith W. Abell
/s/ Sanjay H. Patel
----------------------------------------
Sanjay H. Patel
* The undersigned, by signing his name hereto, executes this Schedule pursuant
to the Power of Attorney executed on behalf of the above-named entities and
individuals and filed herewith.
By: /s/ Stanley de J. Osborne
------------------------------------
Attorney-in-Fact
Page 37 of 39
<PAGE>
EXHIBIT INDEX
Exhibit Description
------- -----------
1. Form of Exchange Agreement, by and between Endo Pharmaceuticals
Holdings Inc. ("Endo") and the stockholders party thereto
2. Endo Warrant, dated as of July 17, 2000, issued by Endo to
Endo Pharma LLC ("Endo LLC")
3. Pre-Merger Warrant Agreement, dated as of July 17, 2000, by and
between Endo and United States Trust Company of New York, as
warrant agent
4. Letter Agreement, dated as of November 26, 1999, by and among Algos
Pharmaceutical Corporation, Endo, Kelso Investment Associates V,
L.P. ("KIA V") and Kelso Equity Partners V, L.P. ("KEP V")
5. Limited Liability Company Agreement of Endo LLC ("Endo LLC"), dated
as of July 14, 2000, by and among the persons party thereto and
each of their Permitted Transferees (as defined therein)
6. Amended and Restated Executive Stockholders Agreement, dated as of
July 14, 2000, by and among Endo, Endo LLC, KIA V, KEP V and the
Management Stockholders (as defined therein)
7. Amended and Restated Employee Stockholders Agreement, dated as of
July 14, 2000, by and among Endo, Endo LLC, KIA V, KEP V and the
Employee Stockholders (as defined therein)
8. Endo LLC Amended and Restated 1997 Employee Stock Option Plan
9. Endo LLC Amended and Restated 1997 Executive Stock Option Plan
10. Endo LLC 2000 Supplemental Employee Option Plan
Page 38 of 39
<PAGE>
11. Endo LLC 2000 Supplemental Executive Option Plan
12. Tax Sharing Agreement, dated as of July 17, 2000, by and among
Endo, Endo Inc. and Endo LLC
13. Treasury Agreement, dated as of July 17, 2000, by and between Endo
and Endo LLC
14. Registration Rights Agreement, dated as of July 17, 2000, by and
between Endo and Endo LLC
15. Joint Filing Agreement, dated as of July 26, 2000
16. Powers of Attorney
Page 39 of 39
